Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000089896

Apexbio Technology LLC Lumiracoxib 220991-20-8 250mg
SDP

Catalog No. 5000089896
Encompass_Preferred

Lumiracoxib (CAS 220991-20-8) is a small molecule that selectively inhibits cyclooxygenase-2 (COX-2) an enzyme involved in prostaglandin synthesis and inflammatory signaling In biochemical assays lumiracoxib demonstrates an IC of 0 14 M and a K of 0 06 M for COX-2 with a selectivity ratio of 515-fold over cyclooxygenase-1 (COX-1) This high degree of isoform selectivity makes lumiracoxib a valuable tool for investigating the specific roles of COX-2 in inflammation and for exploring COX-2 targeted therapeutic strategies in inflammatory and pain-related disorders

Catalog No. 50-000-89896 Supplier Apexbio Technology LLC Supplier No. B1458250
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Lumiracoxib (CAS 220991-20-8) is a small molecule that selectively inhibits cyclooxygenase-2 (COX-2) an enzyme involved in prostaglandin synthesis and inflammatory signaling In biochemical assays lumiracoxib demonstrates an IC of 0 14 M and a K of 0 06 M for COX-2 with a selectivity ratio of 515-fold over cyclooxygenase-1 (COX-1) This high degree of isoform selectivity makes lumiracoxib a valuable tool for investigating the specific roles of COX-2 in inflammation and for exploring COX-2 targeted therapeutic strategies in inflammatory and pain-related disorders

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.